Drug Dependence
48
1
2
42
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Published Results
15 trials with published results (31%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.1%
1 terminated out of 48 trials
97.7%
+11.2% vs benchmark
21%
10 trials in Phase 3/4
36%
15 of 42 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 42 completed trials
Clinical Trials (48)
Tech-Enabled CM for AUD at Scale
Structured Physical Exercise in Short-term Inpatient Treatment of Substance Use Disorder
CB1R in Synthetic Psychoactive Cannabinoids
Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification
Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia
Drug Use During Sex and Its Impact on Taking PrEP (Pre-Exposure Prophylaxis) : CONSUME
Improving Treatment Outcomes for Prescription Opioid Dependence
Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification
Innovative Digital Therapeutic for Smoking Cessation
How to Ease the Withdrawal of Tranquilizers Among Older Consumers?
Extended Release Naltrexone for Opioid-Dependent Youth
Pharmacological, Clinical and Statistical Assessment of a New Tool Available for Pharmacodependence Report Evaluation
HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)
HIV, Buprenorphine, and the Criminal Justice System
Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Integrated Treatment of OEF/OIF Veterans With PTSD & Substance Use Disorders
CBT4CBT for Women in Residential Treatment for Substance Use Disorders
LINK: Aftercare Monitoring Project
Targeting Effective Analgesia in Clinics for HIV - Patient Cohort